North Texas Research Forum 2024



Download Poster or Presentation (416 KB)


North Texas


Medical City Arlington


Internal Medicine

Document Type


Publication Date



acute coronary syndrome, rheumatoid arthritis, RAAS pathway inhibitors


Cardiology | Immune System Diseases | Internal Medicine | Medicine and Health Sciences | Musculoskeletal Diseases


Rheumatoid arthritis (RA) is a chronic multi-system inflammatory disease of which is characterized by articular and extra-articular involvement. Patients with RA have a higher risk of mortality when compared with the general population, which is due predominantly to increased cardiovascular disease. Due to the higher incidence of CVD and MI in RA patients it has been postulated that enhanced systemic inflammation plays an important role in the pathogenesis of CVD in RA patients. Previous studies have shown that ant inflammatory medication such as systemic steroids and immune blockers have been shown to decrease the risk of MI in patients with rheumatoid arthritis. Our results found that there was a decrease in the risk of ACS In patients taking ace inhibitors however the p value was not sustain due to a lack of sample size.

Original Publisher

HCA Healthcare Graduate Medical Education

A Retrospective Study on the Effect of RAAS Pathway Inhibitors at Decreasing the Risk of Acute Coronary Syndrome in Hypertensive Patients with Rheumatoid Arthritis as Compared to Other Antihypertensives



To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.